Learn More
Invitrogen™ TGF beta-1,2,3 Monoclonal Antibody (1D11)

Description
This antibody recognizes human TGF-beta 1, TGF-beta 2, and TGF-beta 3. Reconstitute at 0.5 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method. Neutralization: measured by its ability to neutralize TGF beta-1 inhibition of IL-4-dependent proliferation in the HT-2 mouse T cell line. The Neutralization Dose (ND50) is typically 0.25-1.25 μg/mL in the presence of 1 ng/mL Recombinant Human TGF beta-1 and 7.5 ng/mL Recombinant Mouse IL-4.
Specifications
Specifications
| Antigen | TGF beta-1,2,3 |
| Applications | ELISA, Inhibition Assays, Neutralization, Western Blot |
| Classification | Monoclonal |
| Clone | 1D11 |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 5% trehalose and No Preservative; pH 7.4 |
| Gene | TGFB1 |
| Gene Accession No. | P01137, P04202, P09531, P10600, P16047, P17125, P18341, P21214, P27090, P30371, P61812 |
| Gene Alias | CED; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; tgf beta 1; tgf beta 3; tgf beta1; TGFB; Tgfb1; Tgfb-1; TGFB4; TGFbeta; TGF-beta 1; TGFbeta1; TGF-beta1; TGF-beta-1; TGF-beta4; tissue growth factor-beta4; Transforming growth factor; transforming growth factor beta 1; transforming growth factor beta 4; transforming growth factor beta 4 precursor; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta-1 precursor |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.